Yamashita Suguru, Venkatesan Aradhana M, Mizuno Takashi, Aloia Thomas A, Chun Yun S, Lee Jeffrey E, Vauthey Jean-Nicolas, Conrad Claudius
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston.
JAMA Surg. 2017 Oct 18;152(10):e172986. doi: 10.1001/jamasurg.2017.2986.
Ischemia-reperfusion injury during hepatic resection has been shown to accelerate progression of liver cancer. However, the prognostic relevance of remnant liver ischemia (RLI) after resection of colorectal liver metastases (CLMs) is unknown to date.
To assess the prognostic influence of RLI after resection of CLMs and to identify correlates of greater extent of RLI.
DESIGN, SETTING, AND PARTICIPANTS: This study was a retrospective analysis at The University of Texas MD Anderson Cancer Center based on prospectively collected data. The study identified 202 patients who underwent curative resection of CLMs between January 1, 2008, and December 31, 2014, and had enhanced computed tomographic images obtained within 30 days after surgery.
Remnant liver ischemia was defined as reduced or absent contrast enhancement during the portal phase. Postoperative RLI was classified as grade 0 (none), 1 (marginal), 2 (partial), 3 (segmental), or 4 (necrotic) as previously defined. Experienced members of the surgical team retrospectively performed imaging assessments. Team members were masked to the postoperative outcomes. Survival after resection was stratified by RLI grade. Predictors of RLI grade 2 or higher and survival were identified.
Among 202 patients (median [range] age, 56 [27-87] years; 84 female), the RLI grades were as follows: grade 0 (105 patients), grade 1 (47 patients), grade 2 (45 patients), grade 3 (5 patients), and grade 4 (0 patients). Recurrence-free survival (RFS) and cancer-specific survival (CSS) rates after hepatic resection were worse in patients with RLI grade 2 or higher vs grade 1 or lower (RFS at 3 years, 6.4% [3 of 50] vs 39.2% [60 of 152]; P < .001 and CSS at 5 years, 20.7% [10 of 50] vs 63.7% [97 of 152]; P < .001). A largest metastasis at least 3 cm (OR, 2.74; 95% CI, 1.35-5.70; P = .005), multiple CLMs (OR, 2.51; 95% CI, 1.25-5.24; P = .009), and nonanatomic resection (odds ratio [OR], 3.29; 95% CI, 1.52-7.63; P = .002) were associated with RLI grade 2 or higher. A largest metastasis at least 3 cm (hazard ratio [HR], 1.70; 95% CI, 1.01-2.88; P = .045), mutant RAS (HR, 2.15; 95% CI, 1.27-3.64; P = .005), and RLI grade 2 or higher (HR, 2.90; 95% CI, 1.69-4.84; P < .001) were associated with worse CSS.
In this study, remnant liver ischemia grade 2 or higher was associated with worse CSS after resection of CLMs. High-quality anatomic surgery to minimize RLI after resection is essential.
肝切除术中的缺血再灌注损伤已被证明会加速肝癌进展。然而,结直肠癌肝转移(CLM)切除术后残余肝缺血(RLI)的预后相关性至今尚不清楚。
评估CLM切除术后RLI的预后影响,并确定RLI程度较高的相关因素。
设计、地点和参与者:本研究是在德克萨斯大学MD安德森癌症中心基于前瞻性收集的数据进行的回顾性分析。该研究纳入了202例在2008年1月1日至2014年12月31日期间接受CLM根治性切除且术后30天内获得增强计算机断层扫描图像的患者。
残余肝缺血定义为门静脉期对比增强减弱或消失。术后RLI按先前定义分为0级(无)、1级(边缘性)、2级(部分性)、3级(节段性)或4级(坏死性)。手术团队的经验丰富成员进行回顾性影像评估。团队成员对术后结局不知情。切除术后的生存情况按RLI分级进行分层。确定RLI 2级或更高的预测因素以及生存率。
202例患者(中位[范围]年龄,56[27 - 87]岁;84例女性)的RLI分级如下:0级(105例患者)、1级(47例患者)、2级(45例患者)、3级(5例患者)和4级(0例患者)。RLI 2级或更高的患者与1级或更低的患者相比,肝切除术后的无复发生存率(RFS)和癌症特异性生存率(CSS)更差(3年RFS,6.4%[50例中的3例]对39.2%[152例中的60例];P <.001,5年CSS,20.7%[50例中的10例]对63.7%[152例中的97例];P <.001)。最大转移灶至少3 cm(比值比[OR],2.74;95%置信区间[CI],1.35 - 5.70;P = 0.005)、多个CLM(OR,2.51;95% CI,1.25 - 5.24;P = 0.009)和非解剖性切除(比值比[OR],3.29;95% CI,1.52 - 7.63;P = 0.002)与RLI 2级或更高相关。最大转移灶至少3 cm(风险比[HR],1.70;95% CI,1.01 - 2.88;P = 0.045)、RAS突变(HR,2.15;95% CI,1.27 - 3.64;P = 0.005)和RLI 2级或更高(HR,2.90;95% CI,1.69 - 4.84;P <.001)与更差的CSS相关。
在本研究中,CLM切除术后残余肝缺血2级或更高与更差的CSS相关。进行高质量的解剖性手术以尽量减少切除术后的RLI至关重要。